Dr. Itamar Harel at Hebrew University has caught evolution red-handed, revealing the genetic bargain that lets us sprint through youth at the cost of a slower decline later—and the gene responsible is vgll3. In a landmark study published in Nature Communications, an international team led by Harel, Dr. Eitan Moses, and Dr. Marva Bergman has provided the first direct experimental evidence for a theory biologists have debated for decades: that certain genes deliver early-life advantages while sowing the seeds of aging and disease in old age.
The question has long haunted medicine and evolutionary biology: Why can't our bodies simply maintain themselves indefinitely? The answer, it turns out, is woven into our genetic code. Evolution doesn't prioritize longevity; it prioritizes reproduction. By studying the African turquoise killifish—a short-lived vertebrate that ages remarkably like humans—the researchers identified vgll3 as a key architect of this biological trade-off. The gene has been previously linked to puberty timing in humans and maturation in Atlantic salmon, but until now, scientists lacked functional proof of what this gene actually does.
Using CRISPR technology, the team modified vgll3 in killifish and observed striking effects. Fish carrying the altered gene grew faster and reached sexual maturity earlier—traits that would offer clear reproductive advantages in nature. But the benefits proved fleeting. These same fish experienced reduced lifespans and dramatically increased rates of age-related tumors, including melanoma-like cancers. The cost of early vitality was premature decline.
Further investigation revealed the mechanism behind this bargain. The vgll3 gene influences fundamental biological processes including cell division, stem cell activity, and DNA repair. The accelerated cellular activity that builds a young body turns destructive over time, allowing damage to accumulate until disease takes hold. The researchers even developed a new immunodeficient killifish model to study tumor cells in unprecedented ways, deepening their understanding of how rapid growth and cancer share the same genetic machinery.
What makes this discovery particularly striking is that the cancer emerging in aging fish isn't random misfortune—it's a direct consequence of the same genetic drive that created their youthful vigor. "The cancer we see in these fish isn't a random accident," Harel explained. "It's the direct shadow of their youthful vitality. The same machinery that drives a cell to build a young body is hijacking the system to build a tumor in the old one."
Because vgll3 is conserved across species and present in humans, where earlier studies have linked it to puberty timing and hormone levels, these findings carry implications well beyond the killifish lab. The discovery opens pathways for understanding how to potentially separate healthy growth in youth from the disease processes of aging—a distinction that could reshape cancer prevention and longevity research.
For now, the research stands as a rare moment when evolution's ruthless arithmetic becomes visible: nature built us to reproduce quickly, and the price of that design is paid in our later years. Understanding this trade-off at the genetic level may finally allow us to ask a new question: Can we keep the benefits of growth without inheriting its long-term costs?